OpenURL Connection Search

Select item for more details and to access through your institution.

Predictors of New-Onset Kidney Disease in a Community-Based Population.
Published in:
JAMA: Journal of the American Medical Association, 2004, v. 291, n. 7, p. 844, doi. 10.1001/jama.291.7.844
By:
- Fox, Caroline S.;
- Larson, Martin G.;
- Leip, Eric P.;
- Culleton, Bruce;
- Wilson, Peter W. F.;
- Levy, Daniel
Publication type:
Article
Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction: The Framingham Heart Study.
Published in:
JAMA: Journal of the American Medical Association, 2002, v. 288, n. 10, p. 1252, doi. 10.1001/jama.288.10.1252
By:
- Vasan, Ramachandran S.;
- Benjamin, Emelia J.;
- Larson, Martin G.;
- Leip, Eric P.;
- Wang, Thomas J.;
- Wilson, Peter W. F.;
- Levy, Daniel
Publication type:
Article
Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib.
Published in:
British Journal of Haematology, 2016, v. 172, n. 1, p. 97, doi. 10.1111/bjh.13801
By:
- Brümmendorf, Tim H.;
- Cortes, Jorge E.;
- Khoury, Hanna J.;
- Kantarjian, Hagop M.;
- Kim, Dong‐Wook;
- Schafhausen, Philippe;
- Conlan, Maureen G.;
- Shapiro, Mark;
- Turnbull, Kathleen;
- Leip, Eric;
- Gambacorti‐Passerini, Carlo;
- Lipton, Jeff H.
Publication type:
Article
Long‐term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome–positive leukemia resistant or intolerant to prior therapy.
Published in:
European Journal of Haematology, 2021, v. 106, n. 6, p. 808, doi. 10.1111/ejh.13608
By:
- Cortes, Jorge E.;
- Kantarjian, Hagop M.;
- Mauro, Michael J.;
- An, Fiona;
- Nick, Sonja;
- Leip, Eric;
- Gambacorti‐Passerini, Carlo;
- Brümmendorf, Tim H.
Publication type:
Article
Competing risks for first cardiovascular events after hypertension onset: the Framingham Heart Study
Published in:
2003
By:
- Lloyd-Jones, Donald M.;
- Leip, Eric P.;
- Larson, Martin G.;
- Vasan, Ramachandran S.;
- Levy, Daniel
Publication type:
Abstract
Glycemic status and development of kidney disease: the Framingham Heart Study.
Published in:
2005
By:
- Fox CS;
- Larson MG;
- Leip EP;
- Meigs JB;
- Wilson PWF;
- Levy D;
- Fox, Caroline S;
- Larson, Martin G;
- Leip, Eric P;
- Meigs, James B;
- Wilson, Peter W F;
- Levy, Daniel
Publication type:
journal article
Glycemic Status and Development of Kidney Disease.
Published in:
Diabetes Care, 2005, v. 28, n. 10, p. 2436, doi. 10.2337/diacare.28.10.2436
By:
- Fox, Caroline S.;
- Larson, Martin G.;
- Leip, Eric P.;
- Meigs, James B.;
- Wilson, Peter W. F.;
- Levy, Daniel
Publication type:
Article
Cardiac, Vascular and Hypertension Safety of Bosutinib vs Imatinib for Newly Diagnosed Chronic Myeloid Leukemia in the BFORE Trial.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S294, doi. 10.1016/j.clml.2019.07.243
By:
- Cortes, Jorge E.;
- Brümmendorf, Tim H.;
- Gambacorti-Passerini, Carlo;
- Clark, Richard;
- Leip, Eric;
- Viqueira, Andrea;
- Kota, Vamsi;
- Deininger, Michael
Publication type:
Article
Primary Results of the Phase 4 BYOND Study of Bosutinib for Pretreated Chronic Phase (CP) Chronic Myeloid Leukemia (CML).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S290, doi. 10.1016/j.clml.2019.07.235
By:
- Gambacorti-Passerini, Carlo;
- Abboud, Camille;
- Gjertsen, Bjørn Tore;
- Brümmendorf, Tim;
- Smith, B. Douglas;
- Giraldo-Castellano, Pilar;
- Strömberg, Ulla;
- Saussele, Susanne;
- Bardy-Bouxin, Nathalie;
- Viqueira, Andrea;
- Leip, Eric;
- Leone, Jocelyn;
- Rosti, Gianantonio;
- Watts, Justin;
- Giles, Frank;
- Hochhaus, Andreas
Publication type:
Article
Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias.
Published in:
2017
By:
- Cortes, Jorge E.;
- Gambacorti-Passerini, Carlo;
- Kim, Dong-Wook;
- Kantarjian, Hagop M.;
- Lipton, Jeff H.;
- Lahoti, Amit;
- Talpaz, Moshe;
- Matczak, Ewa;
- Barry, Elly;
- Leip, Eric;
- Brümmendorf, Tim H.;
- Khoury, H. Jean
Publication type:
journal article
Bosutinib (BOS) vs Imatinib (IM) for Newly Diagnosed Chronic Myeloid Leukemia (CML): Initial Results from the BFORE Trial.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S316, doi. 10.1016/j.clml.2017.07.117
By:
- Cortes, Jorge;
- Gambacorti-Passerini, Carlo;
- Deininger, Michael;
- Mauro, Michael;
- Chuah, Charles;
- Kim, Dong Wook;
- Reilly, Laurence;
- Jeynes-Ellis, Alison;
- Leip, Eric;
- Bardy-Bouxin, Nathalie;
- Hochhaus, Andreas;
- Brümmendorf, Tim
Publication type:
Article
Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib.
Published in:
American Journal of Hematology, 2016, v. 91, n. 12, p. 1206, doi. 10.1002/ajh.24536
By:
- Cortes, Jorge E.;
- Khoury, Hanna J.;
- Kantarjian, Hagop M.;
- Lipton, Jeff H.;
- Kim, Dong-Wook;
- Schafhausen, Philippe;
- Matczak, Ewa;
- Leip, Eric;
- Noonan, Kay;
- Brümmendorf, Tim H.;
- Gambacorti-Passerini, Carlo
Publication type:
Article
Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib.
Published in:
American Journal of Hematology, 2016, v. 91, n. 6, p. 606, doi. 10.1002/ajh.24360
By:
- Cortes, Jorge E.;
- Jean Khoury, H.;
- Kantarjian, Hagop;
- Brümmendorf, Tim H.;
- Mauro, Michael J.;
- Matczak, Ewa;
- Pavlov, Dmitri;
- Aguiar, Jean M.;
- Fly, Kolette D.;
- Dimitrov, Svetoslav;
- Leip, Eric;
- Shapiro, Mark;
- Lipton, Jeff H.;
- Durand, Jean-Bernard;
- Gambacorti-Passerini, Carlo
Publication type:
Article
Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors.
Published in:
American Journal of Hematology, 2015, v. 90, n. 9, p. 755, doi. 10.1002/ajh.24034
By:
- Gambacorti-Passerini, Carlo;
- Kantarjian, Hagop M.;
- Kim, Dong-Wook;
- Khoury, Hanna J.;
- Turkina, Anna G.;
- Brümmendorf, Tim H.;
- Matczak, Ewa;
- Bardy-Bouxin, Nathalie;
- Shapiro, Mark;
- Turnbull, Kathleen;
- Leip, Eric;
- Cortes, Jorge E.
Publication type:
Article
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.
Published in:
American Journal of Hematology, 2014, v. 89, n. 7, p. 732, doi. 10.1002/ajh.23728
By:
- Gambacorti-Passerini, Carlo;
- Brümmendorf, Tim H.;
- Kim, Dong-Wook;
- Turkina, Anna G.;
- Masszi, Tamas;
- Assouline, Sarit;
- Durrant, Simon;
- Kantarjian, Hagop M.;
- Khoury, H. Jean;
- Zaritskey, Andrey;
- Shen, Zhi-Xiang;
- Jin, Jie;
- Vellenga, Edo;
- Pasquini, Ricardo;
- Mathews, Vikram;
- Cervantes, Francisco;
- Besson, Nadine;
- Turnbull, Kathleen;
- Leip, Eric;
- Kelly, Virginia
Publication type:
Article
Bosutinib in Combination With the Aromatase Inhibitor Letrozole: A Phase II Trial in Postmenopausal Women Evaluating First-Line Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer.
Published in:
Oncologist, 2014, v. 19, n. 4, p. 348, doi. 10.1634/theoncologist.2014-0021
By:
- Moy, Beverly;
- Neven, Patrick;
- Lebrun, Fabienne;
- Bellet, Meritxell;
- Xu, Binghe;
- Sarosiek, Tomasz;
- Chow, Louis;
- Goss, Paul;
- Zacharchuk, Charles;
- Leip, Eric;
- Turnbull, Kathleen;
- Bardy‐Bouxin, Nathalie;
- Duvillié, Ladan;
- Láng, István
Publication type:
Article
Bosutinib in Combination With the Aromatase Inhibitor Exemestane: A Phase II Trial in Postmenopausal Women With Previously Treated Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer.
Published in:
Oncologist, 2014, v. 19, n. 4, p. 346, doi. 10.1634/theoncologist.2014-0022
By:
- Moy, Beverly;
- Neven, Patrick;
- Lebrun, Fabienne;
- Bellet, Meritxell;
- Xu, Binghe;
- Sarosiek, Tomasz;
- Chow, Louis;
- Goss, Paul;
- Zacharchuk, Charles;
- Leip, Eric;
- Turnbull, Kathleen;
- Bardy‐Bouxin, Nathalie;
- Duvillié, Ladan;
- Láng, István
Publication type:
Article

Found: 17